Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

Saturday, June 29, 2024

Dyadic International Inc announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals a leading supplier

Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

Saturday, June 29, 2024

Sirnaomics Ltd a leading biopharmaceutical company engaging in discovery and development of advanced

Orchid Pharma partners with Cipla to launch antibiotic Cefepime - Enmetazobactam in India

Friday, June 28, 2024

Orchid Pharma Limited based in Chennai India the only Indian pharmaceutical company to have ever invented a New Chemical Entity today announced the launch of its new drug

Leqembi® (lecanemab) launched in China

Friday, June 28, 2024

BioArctic ABs partner Eisai today announced today that Leqembi has been launched in China Leqembi received approval in January as a treatment of mild cognitive impairment due to Alzheimers disease and mild AD dementia China is the third country to l...

Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program

Friday, June 28, 2024

Dynavax Technologies Corporation a commercialstage biopharmaceutical company developing and commercializing innovative vaccines today announced that the first participant has been dosed in a Phase clinical trial

FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia

Friday, June 28, 2024

FSD Pharma Inc a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide

Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea

Thursday, June 27, 2024

Antengene Corporation Limited a leading innovative commercialstage global biopharmaceutical company dedicated to discovering developing and commercializing firstinclass

HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small Molecule GLP-1 Receptor Agonist HDM1002

Thursday, June 27, 2024

HUADONG MEDICINE through its whollyowned subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO LTD has recently announced positive results from Phase I clinical trials

Hyundai Bioscience succeeds in developing 'Multi-treatment for mosquito-borne viral infections' including Dengue Fever

Wednesday, June 26, 2024

Hyundai Bioscience which is preparing for a dengue fever basket clinical trial in Brazil announced on the th that it has successfully developed a multitreatment drug for mosquitoborne viral infections